Insmed Inc.

INSM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2010 FY2009
Revenue $6.9M $10.4M
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $4.7M $9.2M
SG&A Expense $10.3M $9.8M
Operating Income $-8.1M $-8.7M
Operating Margin -116.9% -83.6%
Interest Expense $109.0K $781.0K
Pretax Income $-6.4M $118.8M
Income Tax Expense $78.0K $477.0K
Net Income $-6.4M $118.4M
Net Margin -93.0% 1,140.9%
EPS (Basic) $-0.49 $0.01
EPS (Diluted) $-0.49 $0.01
Shares Outstanding (Basic) 13.3M 13.2M
Shares Outstanding (Diluted) 13.3M 13.2M
Dividends Per Share
← Newer Page 3 of 3 Older →